References:
1. Weitzman I, Summerbell RC: The dermatophytes. Clin Microbiol Rev.
1995, 8:240-259. 10.1128/CMR.8.2.240
2. Zurita J, Hay RJ: Adherence of dermatophyte microconidia and
arthroconidia to human keratinocytes in vitro. J Invest Dermatol. 1987,
89:529-534. 10.1111/1523-1747.ep12461067
3. Calderon RA: Immunoregulation of dermatophytosis. Crit Rev Microbiol.
1989, 16:339-368. 10.3109/10408418909104472
4. Tani K, Adachi M, Nakamura Y, et al.: The effect of dermatophytes on
cytokine production by human keratinocytes. Arch Dermatol Res. 2007,
299:381-387. 10.1007/s00403-007-0780-7
5. Lanternier F, Pathan S, Vincent QB, et al.: Deep dermatophytosis and
inherited CARD9 deficiency. N Engl J Med. 2013, 369:1704-1714.
10.1056/NEJMoa1208487
6. Wang R, Huang C, Zhang Y, Li R: Invasive dermatophyte infection: A
systematic review. Mycoses. 2021, 64:340-348. 10.1111/myc.13212
7. Fiorcari S, Maffei R, Vallerini D, et al.: BTK Inhibition Impairs the
Innate Response Against Fungal Infection in Patients With Chronic
Lymphocytic Leukemia. Front Immunol. 2020, 11:2158.
10.3389/fimmu.2020.02158
8. Little JS, Weiss ZF, Hammond SP: Invasive Fungal Infections and
Targeted Therapies in Hematological Malignancies. J Fungi (Basel). 2021,
7. 10.3390/jof7121058
9. Nasillo V, Lagreca I, Vallerini D, et al.: BTK Inhibitors Impair
Platelet-Mediated Antifungal Activity. Cells. 2022, 11.
10.3390/cells11061003
10. Ruchlemer R, Ben-Ami R, Bar-Meir M, et al.: Ibrutinib-associated
invasive fungal diseases in patients with chronic lymphocytic leukaemia
and non-Hodgkin lymphoma: An observational study. Mycoses. 2019,
62:1140-1147. 10.1111/myc.13001